“The survival rate comparison of non small cell lung carcinoma patients who are given by epidermal growth factor receptor-tyrosin kinase inhibitor and those given by first-line chemotherapy treatment” (2022) Nusantara Medical Science Journal, 6(2), pp. 103–115. doi:10.20956/nmsj.v6i2.18857.